STAAR Surgical Company
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 230.47M | 284.39M | 322.42M | 313.90M | 239.44M | -23.7% | |
| Cost of Revenue | (51.84M) | (61.01M) | (69.76M) | (74.32M) | (57.02M) | -23.3% | |
Gross Profit | 178.64M | 223.38M | 252.65M | 239.58M | 182.42M | -23.9% | |
| Operating Expenses | |||||||
| Research & Development | (33.86M) | (35.98M) | (44.40M) | (53.97M) | (40.05M) | -25.8% | |
| Selling, General & Administrative | (111.44M) | (143.60M) | (180.15M) | (198.22M) | (188.31M) | -5.0% | |
| General & Administrative | (44.14M) | (54.74M) | (72.32M) | (89.90M) | (85.78M) | -4.6% | |
| Selling & Marketing | (67.29M) | (88.86M) | (107.83M) | (108.32M) | (102.53M) | -5.3% | |
| Depreciation & Amortization | (3.64M) | (4.51M) | (5.12M) | (6.89M) | (8.73M) | 26.7% | |
Operating Income (EBIT) | 33.34M | 43.80M | 28.10M | -12.61M | -45.95M | 264.3% | |
| Non-Operating Items | |||||||
| Interest Income | — | 2.45M | 6.99M | 5.91M | 4.59M | -22.3% | |
| Interest Expense | (38.00K) | — | — | — | — | — | |
| Other Income/Expenses (Net) | -2.04M | 1.75M | 5.60M | 3.56M | -36.32M | -1120.4% | |
Income Before Tax | 31.30M | 45.55M | 33.70M | -9.05M | -82.26M | 808.8% | |
| Income Tax Expense | (3.79M) | (5.89M) | (12.35M) | (11.16M) | (1.81M) | -116.3% | |
Net Income | 27.51M | 39.66M | 21.35M | -20.21M | -80.45M | 298.1% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $1 | $0 | $-0 | $-2 | 295.1% | |
| Weighted Avg Shares Outstanding | 47.21M | 47.99M | 48.52M | 49.13M | 49.57M | 0.9% | |
| Weighted Avg Shares Outstanding (Diluted) | 49.46M | 49.38M | 49.43M | 49.13M | 49.57M | 0.9% | |
EBITDA | 34.98M | 50.06M | 38.82M | -2.16M | -73.53M | 3302.8% |
Explore STAA
STAA in the Healthcare
Small Cap